{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T08:03:01Z","timestamp":1758096181637,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijtb.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T19:30:40Z","timestamp":1493407840000},"page":"240-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors affecting outcomes of individualised treatment for drug resistant tuberculosis in an endemic region"],"prefix":"10.1016","volume":"66","author":[{"given":"Avinandan","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preyas J.","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod B.","family":"Chavhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh V.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind H.","family":"Kate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg D.","family":"Leuppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant N.","family":"Chhajed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"Global tuberculosis report 2015","author":"World Health Organization (WHO)","key":"10.1016\/j.ijtb.2017.04.001_bib0115"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0120","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/jac\/dkv354","article-title":"Personalized medicine for patients with MDR-TB","volume":"71","author":"Olaru","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"40","key":"10.1016\/j.ijtb.2017.04.001_bib0125","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.40.20601","article-title":"Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007","volume":"18","author":"Anderson","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/590005","article-title":"Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis","volume":"47","author":"Kwon","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4103\/0970-2113.142101","article-title":"Multidrug-resistant-tuberculosis treatment in the Indian private sector: results from a tertiary referral private hospital in Mumbai","volume":"31","author":"Udwadia","year":"2014","journal-title":"Lung India"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/0970-2113.180799","article-title":"Tuberculosis therapy in Mumbai: critical importance of drug susceptibility testing","volume":"33","author":"Daftary","year":"2016","journal-title":"Lung India"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/0970-2113.120608","article-title":"Clinical profile and treatment outcomes of drug-resistant tuberculosis before directly observed treatment strategy plus: lessons for the program","volume":"30","author":"Dholakia","year":"2013","journal-title":"Lung India"},{"year":"2008","series-title":"Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. Emergency Update 2008","author":"World Health Organization (WHO)","key":"10.1016\/j.ijtb.2017.04.001_bib0150"},{"year":"2011","series-title":"Guidelines for the Programmatic Management of Drug-resistant Tuberculosis \u2013 2011 Update","author":"World Health Organization (WHO)","key":"10.1016\/j.ijtb.2017.04.001_bib0155"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0160","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/ciu619","article-title":"Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis","volume":"59","author":"Bastos","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0165","doi-asserted-by":"crossref","first-page":"e58664","DOI":"10.1371\/journal.pone.0058664","article-title":"Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality","volume":"8","author":"Mitnick","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciu209","article-title":"Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death","volume":"59","author":"Velasquez","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ijtb.2017.04.001_bib0175","doi-asserted-by":"crossref","first-page":"e1001932","DOI":"10.1371\/journal.pmed.1001932","article-title":"Association between regimen composition and treatment response in patients with multidrug-resistant tuberculosis: a prospective cohort study","volume":"12","author":"Yuen","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0180","first-page":"157","article-title":"The revised national tuberculosis control programme: A status report on first 1,00,000 patients","volume":"46","author":"Khatri","year":"1999","journal-title":"Indian J Tuberc"},{"issue":"5","key":"10.1016\/j.ijtb.2017.04.001_bib0185","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/thx.2006.073916","article-title":"Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective","volume":"63","author":"Ditah","year":"2008","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ijtb.2017.04.001_bib0190","first-page":"15","article-title":"Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic","volume":"55","author":"Dhingra","year":"2008","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(05)17786-1","article-title":"Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study","volume":"365","author":"Leimane","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 8","key":"10.1016\/j.ijtb.2017.04.001_bib0200","first-page":"1444","article-title":"Comorbidities and MDR-TB treatment outcomes in Georgia-2009-11 cohort","volume":"44","author":"Kikvidze","year":"2014","journal-title":"Eur Resp J"},{"issue":"1","key":"10.1016\/j.ijtb.2017.04.001_bib0205","doi-asserted-by":"crossref","first-page":"e0116798","DOI":"10.1371\/journal.pone.0116798","article-title":"Resistance patterns among multidrug-resistant tuberculosis patients in Greater Metropolitan Mumbai: trends over time","volume":"10","author":"Dalal","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/09031936.05.00111304","article-title":"Drug-susceptibility testing in tuberculosis: methods and reliability of results","volume":"25","author":"Kim","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0215","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/JCM.02724-12","article-title":"Diagnostic accuracy and reproducibility of WHO-endorsed phenotypic drug susceptibility testing methods for first-line and second-line antituberculosis drugs","volume":"51","author":"Horne","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijtb.2017.04.001_bib0220","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.00120-13","article-title":"WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis","volume":"57","author":"Chang","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570716303997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570716303997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:57:17Z","timestamp":1758081437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570716303997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0019570716303997"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2017.04.001","relation":{},"ISSN":["0019-5707"],"issn-type":[{"type":"print","value":"0019-5707"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors affecting outcomes of individualised treatment for drug resistant tuberculosis in an endemic region","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2017.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}